Isopropyl palmitate
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 596081

CAS#: 142-91-6

Description: Isopropyl palmitate is the ester of isopropyl alcohol and palmitic acid. It is an emollient, moisturizer, thickening agent, and anti-static agent .


Chemical Structure

img
Isopropyl palmitate
CAS# 142-91-6

Theoretical Analysis

MedKoo Cat#: 596081
Name: Isopropyl palmitate
CAS#: 142-91-6
Chemical Formula: C19H38O2
Exact Mass: 298.29
Molecular Weight: 298.510
Elemental Analysis: C, 76.45; H, 12.83; O, 10.72

Price and Availability

Size Price Availability Quantity
25g USD 250 2 Weeks
Bulk inquiry

Synonym: Isopropyl palmitate; HSDB 2647; AI3-05733; BRN 1786567; EINECS 205-571-1; Emcol-IP; Isopropyl hexadecanoate; JA-FA Ipp; NSC 69169; NSC-69169; NSC69169;

IUPAC/Chemical Name: isopropyl palmitate

InChi Key: XUGNVMKQXJXZCD-UHFFFAOYSA-N

InChi Code: InChI=1S/C19H38O2/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-19(20)21-18(2)3/h18H,4-17H2,1-3H3

SMILES Code: CCCCCCCCCCCCCCCC(OC(C)C)=O

Appearance: Liquid

Purity: >97% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 298.51 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Das JM. Bone wax in Neurosurgery: A Review. World Neurosurg. 2018 May 9. pii: S1878-8750(18)30943-4. doi: 10.1016/j.wneu.2018.04.222. [Epub ahead of print] Review. PubMed PMID: 29753076.

2: Karaca T, Korkmaz F. A Quasi-experimental Study to Explore the Effect of Barrier Cream on the Peristomal Skin of Patients With a Tracheostomy. Ostomy Wound Manage. 2018 Mar;64(3):32-39. PubMed PMID: 29584610.

3: Liu W, Zhao Q, Lv L, Yan S, Song Q, Chen T, Yao Q. Pomegranate Seed Oil Enhances the Percutaneous Absorption of trans-Resveratrol. J Oleo Sci. 2018 Apr 1;67(4):479-487. doi: 10.5650/jos.ess17144. Epub 2018 Mar 9. PubMed PMID: 29526870.

4: Algiert-Zielińska B, Mucha P, Rotsztejn H. Comparative evaluation of skin moisture after topical application of 10% and 30% lactobionic acid. J Cosmet Dermatol. 2018 Jan 9. doi: 10.1111/jocd.12485. [Epub ahead of print] PubMed PMID: 29318715.

5: Trimble JO, Light B. Effect of Penetration Enhancers on the Percuaneous Delivery of Hormone Replacement Actives. Int J Pharm Compd. 2017 Nov-Dec;21(6):530-535. PubMed PMID: 29220342.

6: Maqsood M, Ahmed D, Atique I, Malik W. Lipase inhibitory activity of Lagenaria siceraria fruit as a strategy to treat obesity. Asian Pac J Trop Med. 2017 Mar;10(3):305-310. doi: 10.1016/j.apjtm.2017.03.010. Epub 2017 Mar 6. PubMed PMID: 28442115.

7: Tay BY, Yung SC, Teoh TY. Determination and confirmation of isopropyl p-toluenesulfonate in cosmetics by HPLC-diode array detector method and GC-MS. Int J Cosmet Sci. 2016 Dec;38(6):627-633. doi: 10.1111/ics.12342. Epub 2016 Jun 30. PubMed PMID: 27169828.

8: Chiappisi L, Noirez L, Gradzielski M. A journey through the phase diagram of a pharmaceutically relevant microemulsion system. J Colloid Interface Sci. 2016 Jul 1;473:52-9. doi: 10.1016/j.jcis.2016.03.064. Epub 2016 Mar 31. PubMed PMID: 27054766.

9: Alkrad JA, Mrestani Y, Neubert RH. Development and characterization of microemulsions containing hyaluronic acid. Eur J Pharm Sci. 2016 Apr 30;86:84-90. doi: 10.1016/j.ejps.2016.02.008. Epub 2016 Feb 20. PubMed PMID: 26902172.

10: Trimble J, Light B. Effect of Penetration Enhancers on the Percutaneous Delivery of Pain Management Actives. Int J Pharm Compd. 2016 May-Jun;20(3):250-256. PubMed PMID: 28333667.

11: Alsaab H, Alzhrani RM, Boddu SH. Evaluation of the percutaneous absorption of chlorpromazine from PLO gels across porcine ear and human abdominal skin. Drug Dev Ind Pharm. 2016 Aug;42(8):1258-66. doi: 10.3109/03639045.2015.1122610. Epub 2015 Dec 21. PubMed PMID: 26599694.

12: Lu LY, Liu Y, Zhang ZF, Gou XJ, Jiang JH, Zhang JZ, Yao Q. Pomegranate Seed Oil Exerts Synergistic Effects with trans-Resveratrol in a Self-nanoemulsifying Drug Delivery System. Biol Pharm Bull. 2015;38(10):1658-62. doi: 10.1248/bpb.b15-00371. PubMed PMID: 26424027.

13: Liu N, Song W, Song T, Fang L. Design and Evaluation of a Novel Felbinac Transdermal Patch: Combining Ion-Pair and Chemical Enhancer Strategy. AAPS PharmSciTech. 2016 Apr;17(2):262-71. doi: 10.1208/s12249-015-0342-9. Epub 2015 Jun 13. PubMed PMID: 26070544; PubMed Central PMCID: PMC4984900.

14: Pillai AB, Nair JV, Gupta NK, Gupta S. Microemulsion-loaded hydrogel formulation of butenafine hydrochloride for improved topical delivery. Arch Dermatol Res. 2015 Sep;307(7):625-33. doi: 10.1007/s00403-015-1573-z. Epub 2015 May 26. PubMed PMID: 26006164.

15: Damitz R, Chauhan A. Kinetically stable propofol emulsions with reduced free drug concentration for intravenous delivery. Int J Pharm. 2015;486(1-2):232-41. doi: 10.1016/j.ijpharm.2015.03.057. Epub 2015 Mar 31. PubMed PMID: 25839419.

16: Sintov AC. Transdermal delivery of curcumin via microemulsion. Int J Pharm. 2015 Mar 15;481(1-2):97-103. doi: 10.1016/j.ijpharm.2015.02.005. Epub 2015 Feb 2. PubMed PMID: 25655717.

17: Boddu SH, Alsaab H, Umar S, Bonam SP, Gupta H, Ahmed S. Anti-inflammatory effects of a novel ricinoleic acid poloxamer gel system for transdermal delivery. Int J Pharm. 2015 Feb 1;479(1):207-11. doi: 10.1016/j.ijpharm.2014.12.051. Epub 2014 Dec 24. PubMed PMID: 25542985.

18: Boonme P, Boonthongchuay C, Wongpoowarak W, Amnuaikit T. Evaluation of nicotinamide microemulsion on the skin penetration enhancement. Pharm Dev Technol. 2016;21(1):116-20. doi: 10.3109/10837450.2014.971378. Epub 2014 Oct 16. PubMed PMID: 25318786.

19: Boddu SH, Bonam SP, Wei Y, Alexander K. Preparation and in vitro evaluation of a pluronic lecithin organogel containing ricinoleic acid for transdermal delivery. Int J Pharm Compd. 2014 May-Jun;18(3):256-61. PubMed PMID: 25306775.

20: Wu C, Murtaza G, Yameen MA, Aamir MN, Akhtar M, Zhao Y. Permeation study through bacterial cellulose membrane. Acta Pol Pharm. 2014 Mar-Apr;71(2):297-300. PubMed PMID: 25272650.